US Stock MarketDetailed Quotes

PRAX Praxis Precision Medicines

Watchlist
  • 40.240
  • +2.180+5.73%
Close May 2 16:00 ET
  • 40.240
  • 0.0000.00%
Post 20:01 ET
811.37MMarket Cap-3.94P/E (TTM)

Praxis Precision Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
249.53%8.55M
1,349.13%7.46M
-35.47%302K
-54.29%357K
-36.90%431K
2.45M
515K
468K
781K
683K
Operating revenue
249.53%8.55M
1,349.13%7.46M
-35.47%302K
-54.29%357K
-36.90%431K
--2.45M
--515K
--468K
--781K
--683K
Cost of revenue
Gross profit
Operating expense
62.02%208.72M
152.18%71.42M
119.89%57.14M
5.89%37.85M
9.14%42.32M
-40.08%128.82M
-31.68%28.32M
-41.33%25.98M
-40.82%35.74M
-43.68%38.77M
Selling and administrative expenses
33.89%56.31M
52.33%15.13M
74.87%15.26M
4.52%10.59M
15.55%15.33M
-29.85%42.05M
-24.31%9.93M
-37.02%8.72M
-39.63%10.13M
-18.07%13.27M
-General and administrative expense
33.89%56.31M
52.33%15.13M
74.87%15.26M
4.52%10.59M
15.55%15.33M
-29.85%42.05M
-24.31%9.93M
-37.02%8.72M
-39.63%10.13M
-18.07%13.27M
Research and development costs
75.66%152.41M
206.11%56.29M
142.65%41.88M
6.43%27.26M
5.80%26.98M
-44.04%86.77M
-35.09%18.39M
-43.30%17.26M
-41.28%25.61M
-51.56%25.5M
Operating profit
-58.39%-200.17M
-130.01%-63.96M
-122.74%-56.84M
-7.23%-37.49M
-9.96%-41.89M
41.22%-126.37M
32.92%-27.81M
42.39%-25.52M
42.11%-34.96M
44.67%-38.09M
Net non-operating interest income expense
Other net income (expense)
460.27%17.35M
468.64%5.28M
457.13%4.93M
642.44%4.81M
266.82%2.33M
223.51%3.1M
231.43%928K
156.23%884K
224.00%648K
381.82%636K
Other non- operating income (expenses)
460.27%17.35M
468.64%5.28M
457.13%4.93M
642.44%4.81M
266.82%2.33M
223.51%3.1M
231.43%928K
156.23%884K
224.00%648K
381.82%636K
Income before tax
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
Income tax
Net income
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
Net income continuous Operations
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
Minority interest income
Net income attributable to the parent company
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
Basic earnings per share
45.37%-10.21
-50.00%-2.94
-1.10%-2.75
76.42%-1.74
73.16%-2.84
73.17%-18.69
84.98%-1.96
81.11%-2.72
62.73%-7.38
53.29%-10.58
Diluted earnings per share
45.37%-10.21
-50.00%-2.94
-1.10%-2.75
76.42%-1.74
73.16%-2.84
73.17%-18.69
84.98%-1.96
81.11%-2.72
62.73%-7.38
53.29%-10.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 249.53%8.55M1,349.13%7.46M-35.47%302K-54.29%357K-36.90%431K2.45M515K468K781K683K
Operating revenue 249.53%8.55M1,349.13%7.46M-35.47%302K-54.29%357K-36.90%431K--2.45M--515K--468K--781K--683K
Cost of revenue
Gross profit
Operating expense 62.02%208.72M152.18%71.42M119.89%57.14M5.89%37.85M9.14%42.32M-40.08%128.82M-31.68%28.32M-41.33%25.98M-40.82%35.74M-43.68%38.77M
Selling and administrative expenses 33.89%56.31M52.33%15.13M74.87%15.26M4.52%10.59M15.55%15.33M-29.85%42.05M-24.31%9.93M-37.02%8.72M-39.63%10.13M-18.07%13.27M
-General and administrative expense 33.89%56.31M52.33%15.13M74.87%15.26M4.52%10.59M15.55%15.33M-29.85%42.05M-24.31%9.93M-37.02%8.72M-39.63%10.13M-18.07%13.27M
Research and development costs 75.66%152.41M206.11%56.29M142.65%41.88M6.43%27.26M5.80%26.98M-44.04%86.77M-35.09%18.39M-43.30%17.26M-41.28%25.61M-51.56%25.5M
Operating profit -58.39%-200.17M-130.01%-63.96M-122.74%-56.84M-7.23%-37.49M-9.96%-41.89M41.22%-126.37M32.92%-27.81M42.39%-25.52M42.11%-34.96M44.67%-38.09M
Net non-operating interest income expense
Other net income (expense) 460.27%17.35M468.64%5.28M457.13%4.93M642.44%4.81M266.82%2.33M223.51%3.1M231.43%928K156.23%884K224.00%648K381.82%636K
Other non- operating income (expenses) 460.27%17.35M468.64%5.28M457.13%4.93M642.44%4.81M266.82%2.33M223.51%3.1M231.43%928K156.23%884K224.00%648K381.82%636K
Income before tax -48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M
Income tax
Net income -48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M
Net income continuous Operations -48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M
Minority interest income
Net income attributable to the parent company -48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M
Basic earnings per share 45.37%-10.21-50.00%-2.94-1.10%-2.7576.42%-1.7473.16%-2.8473.17%-18.6984.98%-1.9681.11%-2.7262.73%-7.3853.29%-10.58
Diluted earnings per share 45.37%-10.21-50.00%-2.94-1.10%-2.7576.42%-1.7473.16%-2.8473.17%-18.6984.98%-1.9681.11%-2.7262.73%-7.3853.29%-10.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
CG MED EQUIP.
838810
+29.98%
BEOKA
870199
+29.96%
Shenzhen Bromake New Material
301387
+20.01%
4
Zhejiang Hongchang Electrical Technology
301008
+20.00%
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
+20.00%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025

Earnings Season Underway

Earnings season is here. What to know?